Anglia Ruskin Research Online (ARRO)
Browse
European J of Heart Fail - 2023 - - Supplement Article.pdf (236.99 MB)

Utility of a heart failure treatment score (quad score) in predicting early outcomes in patients with heart failure and a reduced ejection fraction

Download (236.99 MB)
journal contribution
posted on 2023-12-15, 15:10 authored by B Li, S Langley, L Zydik, AD Dimarco, JN Dungu

Introduction: International guidelines recommend that the four pillars of heart failure drug therapy including an Angiotensin Converting Enzyme Inhibitor (ACEi) or Angiotensin Receptor Neprilysin Inhibitor (ARNI), Betablocker (BB), Mineralocorticoid Receptor Antagonist (MRA) and Sodium Glucose co-transporter II inhibitor (SGLT2i) are prescribed to patients with heart failure and a reduced ejection fraction (HFrEF) to improve symptoms and prognosis. The greatest benefit is derived with additional drug classes prescribed and at optimum dosing. Despite this, treatment inertia remains a recognized limitation to heart failure drug optimization and is associated with poor outcomes.

History

Volume

25

Issue number

S2

Page range

3-457

Publication title

European Journal of Heart Failure

ISSN

1388-9842

Publisher

Wiley

File version

  • Published version

Language

  • eng

Affiliated with

  • School of Medicine Outputs

Usage metrics

    ARU Outputs

    Categories

    Exports

    RefWorks
    BibTeX
    Ref. manager
    Endnote
    DataCite
    NLM
    DC